Stride, Inc.
NYSE:LRNEducation & Training Services
-$3.49 today
- Market cap
- $3.27B
- Beta
- 0.08
- P/E (TTM)
- 11.3
- EPS (TTM)
- $7.18
Volume 0.60M
Average 0.80M
LRN Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Stride, Inc.NYSE: LRN
Research & Development · Q4 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q4 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 0 | — |
| FY2025 | 2025-06-30 | 0 | — |
| FY2024 | 2024-06-30 | 0 | — |
| FY2023 | 2023-06-30 | 0 | — |
| FY2022 | 2022-06-30 | 0 | — |
Research & Development vs competitors
How LRN compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for LRN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
MHMcGraw Hill, Inc. | LTM Jun 2026 | $270.64M USD | +35.9% | -0.2% | 12.8% |
| LTM Jun 2026 | CN¥132.9M CNY | +16.7% | -26.2% | 3.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | MX$0 MXN | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Aug 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Apr 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding LRN) | — | +16.7% | -13.2% | 0.0% | |
Competitors are the stored peer set for LRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 1.69B | 1.84B | 2.04B | 2.41B | 2.52B |
| Cost of Revenue | 1.09B | 1.19B | 1.28B | 1.46B | 1.57B |
| Gross Profit | 596.48M | 647.07M | 763.6M | 943.92M | 950.6M |
| Gross Margin | 35.4% | 35.2% | 37.4% | 39.2% | 37.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 439.85M | 481.57M | 514M | 524.35M | 499.83M |
| Operating Expenses | 439.85M | 481.57M | 514M | 583.83M | 499.83M |
| Depreciation & Amortization | 97.91M | 110.36M | 109.68M | 114.67M | 126.56M |
| EBITDA | 253.27M | 291.31M | 386.18M | 508.39M | 579.5M |
| EBITDA Margin | 15.0% | 15.9% | 18.9% | 21.1% | 23.0% |
| Operating Income | 156.63M | 165.5M | 249.6M | 360.09M | 450.77M |
| Operating Margin | 9.3% | 9.0% | 12.2% | 15.0% | 17.9% |
| Interest Income | 0 | 0 | 0 | 0 | 23.56M |
| Interest Expense | 8.28M | 8.4M | 8.81M | 10.5M | 11.78M |
| Other Income / Expenses | (9.41M) | 6.71M | 19.07M | 20.85M | (9.61M) |
| Income Before Tax | 147.22M | 172.21M | 268.67M | 380.95M | 441.16M |
| Pre-Tax Margin | 8.7% | 9.4% | 13.2% | 15.8% | 17.5% |
| Income Tax Expense | 40.09M | 45.35M | 64.48M | 93.01M | 102.77M |
| Net Income | 107.13M | 126.87M | 204.18M | 287.94M | 338.19M |
| Net Margin | 6.4% | 6.9% | 10.0% | 12.0% | 13.4% |
| EPS (Basic) | 2.58 | 3.00 | 4.79 | 6.69 | 7.92 |
| EPS (Diluted) | 2.52 | 2.97 | 4.69 | 5.95 | 7.14 |
| Weighted Avg Shares | 41.45M | 42.29M | 42.63M | 43.04M | 42.72M |
| Weighted Avg Shares (Diluted) | 42.44M | 42.73M | 43.54M | 48.41M | 47.33M |
Stride, Inc.
NYSE:LRN
Intrinsic Alpha fair value
Locked
Current Price
$77.78
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.